Abound Wealth Management’s Roivant Sciences ROIV Stock Holding History

Abound Wealth Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107	Buy	+3	New	+$89	﹤0.01%	1269

Other funds holding ROIV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PDM

Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return

Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return

SEIA

Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Abound Wealth Management's ROIV Position: Q2 2026 in Review

Abound Wealth Management opened a new position in Roivant Sciences (ROIV) in Q2 2026: 3 shares worth $107. The stake represents ﹤0.01% of the portfolio and ranks #1269 among its holdings.

44 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Abound Wealth Management held 3 shares of Roivant Sciences worth $107 as of Q2 2026.
Roivant Sciences was a new Abound Wealth Management position in Q2 2026.
Roivant Sciences made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1269 holding.
44 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.